#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency congenital Dementia Pancreatic neuroendocrine tumour Non-small cell lung cancer Alagille syndrome Phenylketonuria Measles Congenital nephrogenic diabetes insipidus Adrenocortical carcinoma Chronic myeloid leukaemia Leukocyte adhesion deficiency type I Colitis ulcerative Niemann-Pick disease Selective polysaccharide antibody deficiency Breast cancer metastatic More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Paraneoplastic neurological syndrome – Trials in Disease Glomerulonephritis membranoproliferative Hereditary angioedema – Trials in Disease Sjogren’s syndrome – Life with Disease Glycogen storage disease type V – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Medulloblastoma recurrent – Basic Information Crigler-Najjar syndrome – Treatment Cholangitis sclerosing – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zanidatamab Methoxsalen LUNSEKIMIG Tisagenlecleucel Berubicin Hydrochloride Axicabtagene Ciloleucel Dirocaftor Befiradol (18F) Minocycline Hydrochloride Ioversol Ace Inhibitors, Plain Dcc-3116 Carcik-Cd19 Cells Altizide Epacadostat Fasudil Hydrochloride Ascorbic Acid PEGZILARGINASE Entecavir Skb264 More therapies…

    Learn about Your Condition

    Diabetic autonomic neuropathy Lichen planopilaris Kaposi's sarcoma Nasopharyngeal cancer Endocrine disorder Crohn's disease Perinatal depression Metabolic surgery Menopause Large cell lung cancer Small cell carcinoma Hyperglycaemia Alport's syndrome Aortic valve disease Type V hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Lamivudine
    • Tenofovir Disoproxil
    Spain

  • Study on Metformin for Reversing Accelerated Aging in People Aged 50+ Living with HIV

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Metformin Hydrochloride
    Spain

  • Study on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    • Budigalimab
    Belgium Denmark France Germany Italy Poland +1

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Doravirine
    • Islatravir
    • Bictegravir
    France Germany Spain

  • Study on the Effects of VH4524184 for Adults Newly Diagnosed with HIV

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Vh4524184
    Italy Spain

  • Study on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination

    Not recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Islatravir
    • Ulonivirine
    • Bictegravir
    France
Previous Page
1 … 7 8 9 10 11 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!